Celldex Therapeutics Inc
SWB:TCE2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Celldex Therapeutics Inc
SWB:TCE2
|
US |
|
I
|
ITV PLC
XMUN:IJ7
|
UK |
|
F
|
Frontline Ltd
F:FRLN
|
BM |
|
Lument Finance Trust Inc
F:70X
|
US |
|
Delek US Holdings Inc
NYSE:DK
|
US |
|
S
|
Societe Generale SA
BMV:GLEN
|
FR |
|
F
|
Fuji Media Holdings Inc
F:FTN
|
JP |
|
S
|
State Street Corp
BMV:STT
|
US |
|
F
|
Fresnillo PLC
F:FNL
|
MX |
|
Perella Weinberg Partners
NASDAQ:PWP
|
US |
|
Atlas Arteria Group
ASX:ALX
|
AU |
Intrinsic Value
The intrinsic value for
Celldex Therapeutics Inc (TCE2) under the Base Case is hidden
EUR.
Compared with the current market price of 36.02 EUR, the stock appears hidden
.
Do our valuations actually work? See backtest results .
TCE2 looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether TCE2 usually does or if today's premium is unusual.
See where today’s valuation sits in TCE2’s own history and what typically happened over the next 12 months after similar periods.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Celldex Therapeutics Inc.
Fundamental Analysis
Revenue & Expenses Breakdown
Celldex Therapeutics Inc
Earnings Waterfall
Celldex Therapeutics Inc
The intrinsic value for
Celldex Therapeutics Inc (TCE2) under the Base Case is hidden EUR.
Compared with the current market price of 36.02 EUR, the stock appears hidden.